Associated Papers
Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array.
Jørgensen S et al.
Basic & Clinical Pharmacology & Toxicology, 2024
Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine.
Brown SA et al.
Journal of Personalized Medicine, 2018
Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations.
Sychev DA et al.
Pharmacogenomics and Personalized Medicine, 2017
Analysis of the CYP2C19 genetic polymorphism in Han and Uyghur patients with cardiovascular and cerebrovascular diseases in the Kashi area of Xinjiang.
Li Y et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 2014
Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.
Tresukosol D et al.
Plos One, 2014
Pharmacogenomics of clopidogrel: evidence and perspectives.
Yin T et al.
Thrombosis Research, 2011
Time-saving multiplex detection of single nucleotide polymorphisms by ultrasensitive DNA microarray.
Ichikawa M et al.
Journal of Biochemistry, 2010
Select a paper to view details